Suppr超能文献

低 CD8+ 密度变化和 R1 手术切缘是符合米兰标准 HCC 患者术后早期复发的独立预测因素。

Low CD8+ Density Variation and R1 Surgical Margin as Independent Predictors of Early Post-Resection Recurrence in HCC Patients Meeting Milan Criteria.

机构信息

Institute of Biomedical Sciences, Department of Pathology and Forensic Medicine, Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania.

National Center of Pathology, Affiliate of Vilnius University Hospital Santaros Clinics, 08406 Vilnius, Lithuania.

出版信息

Curr Oncol. 2024 Sep 10;31(9):5344-5353. doi: 10.3390/curroncol31090394.

Abstract

Our study included 41 patients fulfilling the Milan criteria preoperatively and aimed to identify individuals at high risk of post-resection HCC relapse, which occurred in 18 out of 41 patients (43.9%), retrospectively. We analyzed whole slide images of CD8 immunohistochemistry with automated segmentation of tissue classes and detection of CD8+ lymphocytes. The image analysis outputs were subsampled using a hexagonal grid-based method to assess spatial distribution of CD8+ lymphocytes with regards to the epithelial edges. The CD8+ lymphocyte density indicators, along with clinical, radiological, post-surgical and pathological variables, were tested to predict HCC relapse. Low standard deviation of CD8+ density along the tumor edge and R1 resection emerged as independent predictors of shorter recurrence-free survival (RFS). In particular, patients presenting with both adverse predictors exhibited 100% risk of relapse within 200 days. Our results highlight the potential utility of integrating CD8+ density variability and surgical margin to identify a high relapse-risk group among Milan criteria-fulfilling HCC patients. Validation in cohorts with core biopsy could provide CD8+ distribution data preoperatively and guide preoperative decisions, potentially prioritizing liver transplantation for patients at risk of incomplete resection (R1) and thereby improving overall treatment outcomes significantly.

摘要

我们的研究纳入了 41 例术前符合米兰标准的患者,旨在确定术后 HCC 复发风险较高的个体,41 例患者中有 18 例(43.9%)发生了 HCC 复发。我们对 CD8 免疫组化的全切片图像进行了分析,采用自动分割组织类别和检测 CD8+淋巴细胞的方法。使用基于六边形网格的方法对图像分析输出进行了抽样,以评估 CD8+淋巴细胞在肿瘤边缘的空间分布。将 CD8+淋巴细胞密度指标与临床、影像学、术后和病理变量进行了测试,以预测 HCC 复发。肿瘤边缘 CD8+密度的标准偏差低和 R1 切除是无复发生存(RFS)较短的独立预测因子。特别是,同时存在这两个不良预测因子的患者在 200 天内复发的风险为 100%。我们的研究结果强调了整合 CD8+密度变异性和手术边界以识别米兰标准满足的 HCC 患者中高复发风险组的潜在效用。在有核心活检的队列中进行验证可以提供术前 CD8+分布数据,并指导术前决策,可能会优先考虑对有不完全切除(R1)风险的患者进行肝移植,从而显著提高整体治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16ac/11431076/2120c3308446/curroncol-31-00394-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验